SCHOTT Introduces Prefillable Polymer Syringe for Infusion Therapy Devices - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

SCHOTT Introduces Prefillable Polymer Syringe for Infusion Therapy Devices

Equipment and Processing Report

SCHOTT expanded its range of TopPac prefillable polymer syringes (PFS) to include a 20-mL format that can be used in combination with syringe pumps in infusion therapy. Prefillable syringes significantly reduce the risk of medication errors compared to manual transfer of a drug from a primary container to a disposable syringe. This accuracy is crucial for infusion therapy, in which common medications (e.g., pain medications, anesthetics, and cardiovascular medications) have a narrow safety margin. TopPac PFS are compatible with various syringe pumps, and the exact outer diameter enables automated recognition by the syringe pumps. The syringes are also compatible with intravenous devices (e.g., needleless luer access devices). TopPac PFS’ optimized siliconization ensures consistent gliding forces for smooth drug application and also reduces the interaction of silicone with the drug throughout its shelf life.

Source: Schott

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
9%
All of the above.
45%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
Source: Equipment and Processing Report,
Click here